Research Article
Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study
Table 2
Multivariate Cox analysis for factors affecting DFS and OS of breast cancer patients.
| Factor | Disease-free survival | Overall survival | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age | 1.135 (0.716, 1.798) | 0.591 | 0.992 (0.650, 1.512) | 0.969 | Tumor size | 0.818 (0.542,1.233) | 0.337 | 0.877 (0.593, 1.298) | 0.512 | TNM stage | 0.754 (0.367, 1.552) | 0.444 | 0.898 (0.439, 1.838) | 0.769 | Oncology grade | 1.441 (0.935, 2.221) | 0.098 | 1.099 (0.753, 1.605) | 0.625 | Lymphatic metastasis | 2.181 (1.425, 3.338) | <0.001 | 2.052 (1.370,3.073) | <0.001 | Molecular subtyping | 1.066 (0.812, 1.400) | 0.645 | 1.074 (0.822, 1.404) | 0.600 | ANXA3 expression | 1.569 (1.152, 2.138) | 0.004 | 1.698 (1.240, 2.326) | 0.001 |
|
|